• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1074250-28
Device Problems Difficult To Position (1467); Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524); Device Contamination with Chemical or Other Material (2944)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/13/2013
Event Type  malfunction  
Event Description
It was reported that using an unspecified artery access approach during a procedure of the heavily calcified distal, mid, and proximal right coronary artery (rca) after the guide wire was positioned across the lesion a small balloon dilatation catheter (bdc) was advanced but failed to cross.A rotablator was used and then the lesion was dilated with a bdc.The 2.5 x 28 mm xience xpedition stent delivery system (sds) was advanced to the lesion but failed to cross and was removed from the anatomy.A 4 fr non-abbott support catheter was advanced inside the unspecified guiding catheter and the 2.5 x 28 mm xience xpedition sds was advanced inside with some resistance with the inner lumen of the support catheter, but exited the support catheter.The sds still could not cross the lesion.The xience xpedition sds met resistance but was removed out of the support catheter from the anatomy; the first two rows of the stent implant struts were noted to be stretched distally and some foreign material was observed entangled/caught with the struts around the implant 4th strut row.The xience xpedition sds was not used again.A non-abbott sds was used in the procedure without reported incident.There was no reported adverse patient effect.There was no reported clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
(b)(4) - re-insertion.The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Manufacturer Narrative
(b)(4).Evaluation summary: the device was returned for analysis.The stent damage and foreign material were able to be confirmed.The failure to advance, difficult to position and difficult to remove could not be replicated in a testing environment as it was based on operational circumstances.Based on a visual and dimensional inspection of the returned device, there is no indication of a product deficiency.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.The results of the query of similar incidents in the complaint handling database for this lot did not indicate a manufacturing issue.Based on the reviewed information, no product deficiency was identified.It should be noted the xience xpedition everolimus eluting coronary stent system instructions for use (ifu) states: an unexpanded stent may be retracted into the guiding catheter one time only.An unexpanded stent should not be reintroduced into the artery once it has been pulled back into the guiding catheter.Subsequent movement in and out through the distal end of the guiding catheter should not be performed as the stent may be damaged or/and dislodged from the balloon when retracting the undeployed stent back into the guiding catheter.Based on the reviewed information, no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key3559639
MDR Text Key4074110
Report Number2024168-2014-00130
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/13/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/30/2015
Device Catalogue Number1074250-28
Device Lot Number3071941
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer12/21/2013
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/14/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE WIRE: RINATO
-
-